Trade Edwards Lifesciences - EW CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.20 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023624% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001401% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 0.1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 71.78 |
| Open | 70.88 |
| 1-Year Change | -24.56% |
| Day's Range | 70.88 - 72.2 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 1, 2025 | 71.78 | -0.18 | -0.25% | 71.96 | 72.17 | 70.90 |
| Mar 31, 2025 | 72.38 | 1.92 | 2.72% | 70.46 | 72.68 | 70.25 |
| Mar 28, 2025 | 70.85 | 0.25 | 0.35% | 70.60 | 71.57 | 70.30 |
| Mar 27, 2025 | 71.08 | 0.71 | 1.01% | 70.37 | 71.49 | 70.12 |
| Mar 26, 2025 | 71.02 | 0.22 | 0.31% | 70.80 | 71.30 | 70.12 |
| Mar 25, 2025 | 71.17 | 0.02 | 0.03% | 71.15 | 72.21 | 70.70 |
| Mar 24, 2025 | 71.13 | 0.98 | 1.40% | 70.15 | 72.16 | 70.15 |
| Mar 21, 2025 | 70.36 | 0.23 | 0.33% | 70.13 | 70.42 | 69.55 |
| Mar 20, 2025 | 70.87 | 0.72 | 1.03% | 70.15 | 71.76 | 69.88 |
| Mar 19, 2025 | 70.79 | 0.59 | 0.84% | 70.20 | 71.12 | 69.86 |
| Mar 18, 2025 | 70.25 | 0.30 | 0.43% | 69.95 | 71.00 | 69.88 |
| Mar 17, 2025 | 70.55 | 1.71 | 2.48% | 68.84 | 70.98 | 68.52 |
| Mar 14, 2025 | 69.02 | 1.03 | 1.51% | 67.99 | 69.59 | 67.50 |
| Mar 13, 2025 | 67.88 | -0.60 | -0.88% | 68.48 | 68.48 | 67.23 |
| Mar 12, 2025 | 68.44 | 0.09 | 0.13% | 68.35 | 70.63 | 68.19 |
| Mar 11, 2025 | 68.32 | 0.42 | 0.62% | 67.90 | 68.93 | 67.57 |
| Mar 10, 2025 | 68.43 | -1.05 | -1.51% | 69.48 | 69.70 | 68.10 |
| Mar 7, 2025 | 70.24 | -0.62 | -0.87% | 70.86 | 71.13 | 69.21 |
| Mar 6, 2025 | 71.71 | 0.25 | 0.35% | 71.46 | 73.01 | 71.46 |
| Mar 5, 2025 | 72.77 | 2.02 | 2.86% | 70.75 | 73.13 | 70.73 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Edwards Lifesciences Company profile
About Edwards Lifesciences Corp
Edwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. The Company is engaged in patient-focused innovations for structural heart disease and critical care monitoring. Its segments include United States, Europe, Japan and Rest of World. Its products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart and Critical Care. It also develops hemodynamic and noninvasive brain and tissue oxygenation monitoring systems that are used to measure a patient's cardiovascular function in the hospital setting. The Edwards SAPIEN family of valves, including Edwards SAPIEN XT, the Edwards SAPIEN 3, and the Edwards SAPIEN 3 Ultra transcatheter aortic heart valves are used to treat heart valve disease.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Edwards Lifesciences Corp revenues increased 19% to $5.23B. Net income increased 83% to $1.5B. Revenues reflect Transcatheter Aortic Valve Replacement segment increase of 20% to $3.42B, Surgical Heart Valve Therapy segment increase of 17% to $889.1M, Critical Care segment increase of 15% to $834.9M, United States segment increase of 18% to $2.96B, Europe segment increase of 26% to $1.19B.
Equity composition
Common Stock $1 Par, 12/10, 350M auth., 117,100,000 issd. less 2,000 shs. in Treas. @ $102M. Insiders control 0.64%. 4/3/00,Company spun off from Baxter International. 05/10, 2-for-1 stock split. 12/15, 2-for-1 stock split.
| Industry: | Advanced Medical Equipment & Technology (NEC) |
One Edwards Way
IRVINE
CALIFORNIA 92614
US
News
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025
Coffee price forecast: 2025-2030 third-party coffee target
Coffee prices have cooled considerably in the past few months. Is a rebound in store or will they continue to fall?
09:42, 12 March 2025
The Simpsons predicted XRP to hit $589: Has the show got it right again?
Did the animated TV show predict a breakout for the XRP cryptocurrency?
11:00, 11 March 2025
Rolls-Royce share price forecast: third- party price target
Our Rolls-Royce share price forecast looks at the outlook for the FTSE 100-listed engineering company after a tough few years.
14:58, 10 March 2025
Gasoline petrol price forecast 2025-2030: Third-party price target
Discover third-party gasoline (petrol) price predictions for 2025 and beyond, with analyst targets, historical prices, and trading strategies.
10:27, 3 March 2025
USD forecast - third party data round up
The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.
10:02, 27 February 2025
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025People also watch
Still looking for a broker you can trust?
Join the 710,000+ traders worldwide that chose to trade with Capital.com